- Real Goods Solar, Inc. RGSE shares jumped 224.1 percent to $2.66 following announcement of exclusive license agreement with Dow to commercialize POWERHOUSE solar shingles system.
- Medical Transcription Billing Corp MTBC shares gained 23.1 percent to $3.89 after surging 109.27 percent on Tuesday.
- Motif Bio plc - ADR MTFB shares jumped 20.1 percent to $12.19 after the company disclosed that Iclaprim achieved primary endpoint of non-inferiority vs vancomycin in REVIVE-2 Phase 3 study.
- Mylan N.V. MYL jumped 18.3 percent to $38.48 after the company reported the FDA approval of first generic for Copaxone 40 mg/mL 3-times-a-week.
- Catabasis Pharmaceuticals Inc CATB gained 18.2 percent to $3.34 after the company disclosed positive results from open-label extension of Phase 2 MoveDMD trial evaluating edasalonexent.
- CytomX Therapeutics Inc CTMX shares surged 16.3 percent to $22.09. Amgen, Inc. AMGN and CytomX reported a strategic collaboration in immuno-oncology.
- Thermon Group Holdings Inc THR jumped 15.1 percent to $21.18 as the company reported the acquisition of CCI Thermal Technologies for CAD $258 million.
- NewLink Genetics Corp NLNK gained 15.1 percent to $12.55. NewLink Genetics priced its 5 million share common stock offering at $10.25 per share.
- Intelsat SA I gained 13.4 percent to $6.09 after gaining 10.95 percent on Tuesday.
- Capstone Turbine Corporation CPST gained 9.9 percent to $0.770. Oppenheimer upgraded Capstone Turbine from Perform to Outperform.
- Amicus Therapeutics, Inc. FOLD climbed 8.6 percent to $16.16 as the company announced additional positive data in Pompe disease Phase 1/2 study at the World Muscle Society.
- Capricor Therapeutics Inc CAPR climbed 7.6 percent to $3.53 after reporting positive six-month results in DMD at the World Muscle Society International Congress.
- 21Vianet Group Inc VNET jumped 7.6 percent to $6.25. Morgan Stanley upgraded 21Vianet Group from Equalweight to Overweight.
- Qualstar Corporation QBAK gained 7.4 percent to $7.18 as the company disclosed that its subsidiary, N2Power, Inc., received $2.0 million in orders from existing OEM gaming customers.
- Viking Therapeutics Inc VKTX shares rose 4.1 percent to $1.81 after the company reported 'positive' top-line results from proof-of-concept study of VK0214.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
